Anish Bhatnagar - 26 May 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role: Chief Executive Officer, Director
Signature: /s/ Anish Bhatnagar
Issuer symbol: SLNO
Transactions as of: 26 May 2023
Net transactions value: $0
Form type: 4
Filing time: 26 May 2023, 18:26:29 UTC
Previous filing: 10 May 2023
Next filing: 13 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLNO	Common Stock	Award	$0	+160,602	+560%	$0.000000	189,283	26 May 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLNO	Employee stock option (right to buy)	Award	$0	+481,806		$0.000000	481,806	26 May 2023	Common Stock	481,806	$5.25	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on November 26, 2023, subject to the Reporting Person continuing to be a Service Provider through such date.
F2	Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3	One thirty-sixth of the shares subject to the Option shall vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.